Cambridge Healthtech Institute’s 4th Annual

Improving Site-Study Activation and Performance:  

Strategically Implementing a Process for Rapid Study Start-Up
January 25-26, 2017 | Hyatt Regency Miami | Miami, FL


Dear Colleague:

I am pleased to announce production of CHI’s 4th Annual “Improving Site-Study Activation and Performance” being held January 25-26, 2017 at the Hyatt Regency in Miami, FL.

The gathering will be part of the 8th Annual Summit for Clinical Trials Operations Executives (SCOPE), a three-day cluster of events that attracted 1,150 leaders in clinical operations and research in January 2017. Please see the overall program map below for 2017. Topics to be discussed at the “Improving Site-Study Activation and Performance” conference include:

  • Improving the study feasibility process, contract and budget negotiations, standardization of source documents and other study-related materials, development of patient and staff educational materials, and development of patient recruitment and retention programs
  • Taking into account operational aspects of clinical trials that have significant impact: Feasibility studies, site selection, budgeting and contracting
  • Optimizing site, CRO, and sponsor interactions
  • Virtual Trials & Remote Trials: What is the future of truly patient-centric trials and how do we do this now?
  • Improving clinical study planning and modeling through patient-centric initiatives: Virtual trials, online patient recruitment, ePRO, social media, mHealth
  • Cost differentiators in protocol feasibility/planning and rescue study programs
  • Research Know How: Site GCP knowledge and payments drive successful R&R campaigns
  • Optimizing clinical trials to give sponsor teams a framework for evaluating their clinical trial strategy/planning/patient centricity
  • Site selection and study planning considerations: Understanding regional issues, regulatory landscapes, and local ethics processes
  • Understanding your protocol and its burden on your clin ops teams, sites and patients: Decide on patient cohort and strategy early prior to going into tactics
  • Overcoming challenges in clinical operations and site management: Linking sponsors, service providers and investigative sites and positioning sites for success by anticipating their needs
  • Innovative approaches to ensure compliance and improve quality (QbD, risk management, risk-based monitoring, remote monitoring, new regulations)
  • Optimizing the Grant Payments Process
  • Improving operational efficiencies in site, CRO, and sponsor interactions: Implementing strategic relationships and other forms of partnerships
  • Identifying the right investigators for your study and then implementing a process for effective communication
  • Driving innovation in study start-up: Optimizing processes, training leaders and leveraging technology

If you are interested in presenting, please click here.

Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academic/hospital centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Deadline for submission is June 15, 2016.

2017 SCOPE Conference at a Glance

SCOPE 2016 Wrap-Up

The 7th Annual SCOPE Summit, held February 23-25, 2016 in Miami, Florida, had record attendance with more than 1,150 industry leaders joining 3 days of in-depth discussions covering important issues in clinical trial planning and management. As SCOPE grew in attendance by 30% over last year, the 2016 program offered 12 distinct conference tracks, 2 symposia, 3 short courses, and 4 plenary keynote sessions, focused on advances and innovative solutions in all aspects of clinical trial management and operations, including Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Statistics and Biomarker-Driven Trials.

For Further Information

For questions or suggestions about the meeting, please contact:

Micah Lieberman
Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
T: (+1) 541.482.4709
E: mlieberman@healthtech.com

For partnering and sponsorship information, please contact:

Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5457
E: iquigley@healthtech.com

For media and association partnerships, please contact:

Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5456
E: rhandy@healthtech.com



Submit A Speaker Proposal

2017 SCOPE Conference at a Glance

Scope Final Agenda 2016  

Signature Sponsor

Bio Clinica Logo

Premier Sponsors

BBK  

ClinicalInk

Comprehend

OmniComm

PRA Health Sciences

QUINTILES

> All Sponsors

> Media Partners

> 2016 Attendee List

> 2016 Attendee Profile